The widespread availability of OGA inhibitors, most notably Thiamet-G, which can be obtained from a wide variety of commercial vendors, has enabled exploration of the therapeutic potential of OGA inhibition in various neurodegeneration disease models. The gene discussed is OGA; the disease is Neurodegeneration.